The Latest: FDA advisers endorse gene therapy for blindness
The Latest on an FDA panel's discussion on a gene therapy treatment for blindness (all times local): 3:19 p.m.
Tesla recalling 11,000 Model X SUVs for seat issue
Tesla Inc. is recalling 11,000 Model X SUVs worldwide because their rear seats might not lock into place.
Trump executive order: What’s next for health reform?
Trump health reform executive order
Trump's health care order: What's in it?
President Donald Trump signed an executive order on Thursday, aimed at expanding access to health care coverage and bringing down related costs.
Trump: ObamaCare has been a nightmare
Trump signs executive order on health reform
Trump order to roll back some Obamacare requirements: White House
U.S. President Donald Trump on Thursday will sign an executive order aiming to make it easier for Americans to buy bare-bones health insurance plans and to circumvent rules put in place under Obamacare, the White House said on Thursday.
Japan's Kobe Steel reports wider fudging of metals data
The Japanese government is urging steelmaker Kobe Steel to clarify the extent of manipulation of data on steel, aluminum and other metals used in a wide range of products, reportedly including rockets, aircraft and cars.
Kroger and JetBlue rise while Coach and Sears slump
Stocks that moved substantially or traded heavily Wednesday: Kroger Co., up 25 cents to $20.78 The grocery store chain said it will consider selling its convenience store business.
Foxconn official: No word on second site until 2018
A Foxconn Medical Group official says no decision will be made on whether the electronics giant will open a secondary facility in Wisconsin until next year.
Trump health coverage alternatives may pose risk to the sick
The White House is working on a plan that could bring more health insurance choices and cheaper options to people buying individual and small business coverage.
Business Highlights
___ P&G, in early vote, fends off activist investor Nelson Peltz Initial voting results show that Procter & Gamble successfully fended off an attempt activist investor Nelson Peltz to capture a seat on its board.
Correction: Genetic Frontiers-Blindness-Gene Therapy story
Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at improving vision for some people with hereditary blindness.
French public sector strike disrupt schools, hospitals
A strike by French public sector workers is affecting schools, hospitals and public services and causing disruptions in domestic air traffic.
Pfizer considers consumer business sale
Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription.
Pharma's Puerto Rico problems could mean drug shortages in US
The head of the U.S. Food and Drug Administration said on Tuesday the country may start to see a small number of drug shortages within two or three weeks due to delays in restoring manufacturing operations in Puerto Rico, where 10 percent of drugs prescribed in the United States are made.
Trump says likely to sign new health care order this week
President Donald Trump said on Tuesday he would sign a measure, likely this week, to allow people in the United States to buy healthcare across state lines.
The Latest: French protesters express fear of more cutbacks
The Latest on France's public sector strike and demonstration (all times local): 4:30 p.m. Police are using tear gas and batons to push back protesters throwing projectiles at a demonstration in Paris over public sector job cuts and salary freezes.
Pfizer weighs sale of consumer healthcare business
Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth as much as $14 billion up for grabs.
Pfizer may sell consumer unit
Pfizer may sell its consumer health care business, which includes the Advil brand, as part of a strategic review.
Asia shares mixed as Wall Street rally takes breather
US stocks are opening mixed as health care and industrial companies fall while technology companies gain ground.














